戒酒对酒精性肝硬化患者肝细胞癌风险的影响
该前瞻性研究纳入727例酒精性肝硬化患者(247例代偿期,480例既往失代偿),中位随访54个月,48.7%保持戒酒,104例发生肝细胞癌(2.3/100人年)。戒酒仅在没有既往失代偿的患者中显著降低肝细胞癌风险(HR 0.35,95%CI 0.13-0.94),而在既往失代偿患者中无此关联(HR 0.95,95%CI 0.59-1.52)。
要点
- 戒酒可降低无既往失代偿的酒精性肝硬化患者肝细胞癌风险。
- 既往失代偿的肝硬化患者戒酒未显示降低肝细胞癌风险。
- 应早期诊断酒精性肝病并促进患者戒酒。
核心结论
- 戒酒降低酒精性肝硬化患者肝细胞癌风险,但仅限于无既往失代偿病史者。
研究设计与样本
- 前瞻性队列研究,纳入727例酒精性肝硬化患者(247例代偿期,480例既往失代偿),均进入肝细胞癌早期监测程序并前瞻随访。
主要发现
- 中位随访54个月,354例(48.7%)保持戒酒,104例发生肝细胞癌(2.3/100人年)。
- 既往失代偿患者中,与肝细胞癌风险独立相关的因素为年龄、男性性别和天冬氨酸氨基转移酶,戒酒与风险降低无关(HR 0.95;95%CI 0.59-1.52)。
- 无既往失代偿患者中,凝血酶原活性和戒酒与肝细胞癌风险独立相关,戒酒者发生肿瘤风险显著降低(HR 0.35;95%CI 0.13-0.94)。
- 以死亡和肝移植为竞争事件的竞争风险分析后结果不变。
临床怎么用
- 对酒精性肝硬化患者应尽早诊断并实施策略提高戒酒率及维持戒酒。
- 对无既往失代偿的酒精性肝硬化患者,戒酒可作为降低肝细胞癌风险的重要措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Although alcohol cessation is the only effective treatment for alcohol-related liver disease, few data exist concerning its influence on the risk of hepatocellular carcinoma (HCC). We aimed to evaluate the effect of alcohol abstinence on the incidence of HCC in patients with alcohol-related cirrhosis. METHODS: We studied 727 patients with alcohol-related cirrhosis (247 with compensated disease and 480 with previous decompensation) who were included in a surveillance program for the early detection of HCC and prospectively followed. Baseline clinical and biological parameters and alcohol consumption during follow-up were recorded. Abstinence was defined as the absence of any alcohol use. RESULTS: During follow-up (median 54 months), 354 patients (48.7%) remained abstinent and 104 developed HCC (2.3 per 100 person-years). Factors independently associated with the risk of HCC among patients with previous decompensation were age, male gender, and aspartate aminotransferase, whereas abstinence was not linked to a reduced risk (hazard ratio 0.95; 95% confidence interval 0.59-1.52). However, among patients without previous decompensation, prothrombin activity and abstinence were independently associated with the risk of HCC. Abstinent patients had a significant decrease in the risk of developing tumor (hazard ratio 0.35; 95% confidence interval 0.13-0.94). These results did not change after applying a competing risk analysis where death and liver transplantation were considered as competing events. DISCUSSION: Alcohol abstinence reduced the risk of HCC in patients with alcohol-related cirrhosis, but only in those without a history of decompensated disease. This finding emphasizes the need for an early diagnosis of alcohol-related liver disease and for implementing strategies leading to an increase in the rate of achieving and maintaining abstinence among this population.
引用
- Rodríguez M, González-Diéguez ML, Varela M, et al. Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis. Am J Gastroenterol. 2021. PMID: 34569986. doi:10.14309/ajg.0000000000001399
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。